- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Algotec builds OEM business
Algotec builds OEM businessIsraeli PACS software developer Algotec has signed a reseller agreement with Toshiba Medical Systems, which will be selling Algotec’s MediSurf and MediStore products in conjunction with Toshiba’s PACS
Algotec builds OEM business
Israeli PACS software developer Algotec has signed a reseller agreement with Toshiba Medical Systems, which will be selling Algotecs MediSurf and MediStore products in conjunction with Toshibas PACS offerings in the Japanese market. A first joint installation has been completed.
Other OEM channels for the company have also begun to pay dividends. Algotec, which serves as a medical imaging marketing partner with HIS firm Eclipsys (PNN 8/98), has completed its first joint installation with the Atlanta-based firm at Childrens Hospital in Columbus, OH.
In addition, Algotec has also been awarded its first large-scale PACS contract from North York General Hospital in Toronto. Implementation will take place through 2000.
The company is ramping up its North American sales and support efforts, which are handled by Algotecs Duluth, GA-based subsidiary, Algotec Inc. Five sales and support engineers are employed by Algotecs U.S. operations, and that number is expected to double by the end of 1999, according to the firm.
- Search again
- Homepage
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
